Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says
In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored
NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain
Sen. Pryor Attacks Drug Industry, NIH Technology Transfer
Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts
Trial Needed Of PSA To Determine Patients To Test, Chabner Says
DCT Advisors Okay PA In Imaging Patters Of Care RFA; Contracts
IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes
Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Friends publishes three white papers ahead of annual meeting
Topics: Clinical trials on rare cancers, combination drug trials, multi-regional studies - Jonathan Licht named president, chief scientific officer at Van Andel Institute
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA









